Xinomiline

This classification denotes an anti-lipidemic agent with the molecular formula C5H10N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Q22EPG4O8, chemically known as 4,5-dihydro-4,4-dimethyl-2-oxazolamin but generally known as xinomiline, which bears US NIH Compound Identifier 3085023. European Medicines Agency schedules Xinomiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00115MIG. The term XINOMILINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). XINOMILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule xinomiline under HS 29349990 and SITC 51579. As of Q4 2014, XINOMILINE remains the US FDA Preferred Term for this commodity. Xinomiline bears US NLM identifiers UMLS ID C1883579 and NCI Concept Code C66671. SMILES: O1CC(N=C1N)(C)C.